MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Non-Current Deffered Revenue (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Non-Current Deffered Revenue came in at $65.1 million in Q4 2025, up 13.1% YoY from $57.6 million in Q4 2024, and up 1.42% on a QoQ basis from $64.2 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Non-Current Deffered Revenue data on file, last reported at $65.1 million in Q4 2025.

  • Quarterly Non-Current Deffered Revenue rose 13.1% year-over-year to $65.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65.1 million (up 13.1% YoY) and the FY2025 annual result came in at $65.1 million, up 13.1% from the prior year.
  • Non-Current Deffered Revenue climbed to $65.1 million in Q4 2025, from $64.2 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $65.1 million in Q4 2025 to a low of $15.5 million in Q3 2022.
  • A 5-year average of $42.2 million and a median of $41.2 million in 2021 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue tumbled 52.33% — and 2024, when it surged 153.99%.
  • Tracing MGTX's Non-Current Deffered Revenue over 5 years: stood at $43.0 million in 2021, then tumbled by 36.26% to $27.4 million in 2022, then rose by 23.99% to $34.0 million in 2023, then surged by 69.26% to $57.6 million in 2024, then advanced by 13.1% to $65.1 million in 2025.
  • The last three Non-Current Deffered Revenue figures came in at $65.1 million (Q4 2025), $64.2 million (Q3 2025), and $63.0 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 11.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.10 Mn
Dec 31, 2025 65.12 Mn
Sep 30, 2025 64.21 Mn
Jun 30, 2025 63.04 Mn
Mar 31, 2025 59.62 Mn
Dec 31, 2024 57.58 Mn
Sep 30, 2024 58.90 Mn
Jun 30, 2024 53.76 Mn
Mar 31, 2024 53.33 Mn
Dec 31, 2023 34.02 Mn
Sep 30, 2023 23.19 Mn
Jun 30, 2023 25.36 Mn
Mar 31, 2023 26.43 Mn
Dec 31, 2022 27.44 Mn
Sep 30, 2022 15.49 Mn
Jun 30, 2022 21.34 Mn
Mar 31, 2022 37.28 Mn
Dec 31, 2021 43.05 Mn
Sep 30, 2021 32.49 Mn
Jun 30, 2021 39.33 Mn